Maintenance notice: Some features that submit or update information are temporarily disabled while we migrate the website. You can continue browsing normally. Thank you for your understanding.
Here are six key trends in the market:
1. The bone graft substitutes market is valued at over $21 million.
2. DePuy Synthes is the leading player in the market. The company is known for its tricalcium phosphate-based ChronOs portfolio and Norian.
3. DePuy also released the first commercial demineralized bone matrix product in the Australian market.
4. There was acceleration in the growth rate of procedures and average selling prices between 2012 and 2014, driven by the introduction and rapid commercial expansion of the DBM product.
5. Stryker is the second leading player in the market.
If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!
Improving orthopaedic care, education and research using Internet technologies